olmesartan has been researched along with Heart Failure in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (34.78) | 29.6817 |
| 2010's | 13 (56.52) | 24.3611 |
| 2020's | 2 (8.70) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Jiang, Z; Li, Y; Peng, Y; Shi, S; Song, J | 1 |
| Asai, K; Kamiya, M; Mizuno, K; Murai, K; Noma, S; Sato, N; Shimizu, W; Shirakabe, A | 1 |
| Grimm, D; Krüger, M; Nielsen, PM; Simonsen, U; Wehland, M | 1 |
| Aichner, S; Albrecht, D; Bremerich, J; Delles, C; Freyhardt, P; Heye, T; Hrabak-Paar, M; Janka, R; Keicher, C; Khder, Y; Langenickel, T; Mayr, M; Ott, C; Schmieder, RE; Wagner, F; Yates, D | 1 |
| Busby, J; Cardwell, CR; Hughes, C; Johnston, BT; McMenamin, Ú; Spence, A | 1 |
| Miura, M; Miyata, S; Nochioka, K; Sakata, Y; Shiba, N; Shimokawa, H; Tadaki, S; Takada, T | 1 |
| Hirose, M; Kashihara, T; Matsushita, N; Mende, U; Nakada, T; Sanbe, A; Shimojo, H; Suzuki, S; Taira, E; Takeishi, Y; Yamada, M | 1 |
| Cao, FF; Jiang, ZL; Li, YF; Liu, F | 1 |
| Fukuchi, M; Goto, T; Hiramoto, T; Ibayashi, S; Inoue, K; Ishide, N; Kato, A; Komaru, T; Maruyama, Y; Miura, M; Miyata, S; Nakagawa, M; Nochioka, K; Nozaki, E; Ohe, M; Saga, C; Sakata, Y; Sekiguchi, N; Shiba, N; Shimokawa, H; Shinozaki, T; Sugi, M; Takada, T; Takahashi, J; Tamaki, K; Tsuji, I | 2 |
| Cheng, XW; Izawa, H; Kim, W; Kobayashi, M; Kuzuya, M; Murohara, T; Nagata, K; Nishizawa, T; Obata, K; Okumura, K; Sasaki, T; Sato, K; Shi, GP; Yamada, T; Yokota, M | 1 |
| Abe, H; Adachi, H; Hattori, S; Irino, H; Kitada, H; Miyatake, K; Morisawa, D; Noda, Y; Sasaki, T; Yasuoka, Y | 1 |
| Inagaki, K; Mochly-Rosen, D; Palaniyandi, SS | 1 |
| Cheng, XW; Harada, K; Hirashiki, A; Inoue, A; Jin, Z; Kuzuya, M; Murohara, T; Nagata, K; Obata, K; Okumura, K; Shi, GP; Takeshita, K; Unno, K; Yokota, M | 1 |
| Fukushima, H; Ishimitsu, T; Kobayashi, N; Koguchi, W; Takeshima, H | 1 |
| Akcay, A; Bavbek, N; Isik, A; Kargili, A; Kasapoglu, B; Kirbas, I | 1 |
| Gurusamy, N; Kodama, M; Lakshmanan, AP; Ma, M; Sukumaran, V; Suzuki, K; Thandavarayan, RA; Veeraveedu, PT; Watanabe, K; Yamaguchi, K | 1 |
| Gurusamy, N; Kodama, M; Lakshmanan, AP; Ma, M; Nagata, M; Sukumaran, V; Suzuki, K; Takagi, R; Veeraveedu, PT; Watanabe, K; Yamaguchi, K | 1 |
| Hamada, J; Kobara, M; Nakata, T; Noda, K; Shiraishi, T; Tanaka, T; Toba, H; Wang, J; Yoshifuji, Y | 1 |
| Fujita, M; Hirata, A; Hori, M; Kitakaze, M; Liao, Y; Minamino, T; Nagamachi, Y; Nakatani, T; Ogawa, S; Okada, K; Ozawa, K; Takashima, S; Tomoike, H; Tsukamoto, O; Tsukamoto, Y; Yutani, C | 1 |
| Hori, M; Mano, T; Masuyama, T; Miwa, T; Nishio, M; Ohtani, T; Sakata, Y; Takeda, Y; Yamamoto, K; Yoshida, J | 1 |
| Mitsuyama, S | 1 |
| Berry, NC; Inagaki, K; Koyanagi, T; Mochly-Rosen, D; Sun, L | 1 |
2 review(s) available for olmesartan and Heart Failure
| Article | Year |
|---|---|
The Combination of Valsartan and Sacubitril in the Treatment of Hypertension and Heart Failure - an Update.
Topics: Aminobutyrates; Angiotensin Receptor Antagonists; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Clinical Trials as Topic; Drug Combinations; Heart Failure; Humans; Hypertension; Imidazoles; Natriuretic Peptides; Neprilysin; Renin-Angiotensin System; Tetrazoles; Treatment Outcome; Valsartan | 2018 |
[ARB: characteristics, mechanisms of action, pharmacokinetics, indication, contraindication, clinical data, and side effects].
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Biphenyl Compounds; Clinical Trials as Topic; Contraindications; Heart Failure; Humans; Hypertension; Imidazoles; Losartan; Telmisartan; Tetrazoles; Valine; Valsartan | 2007 |
5 trial(s) available for olmesartan and Heart Failure
| Article | Year |
|---|---|
The effect of sacubitril/valsartan compared to olmesartan on cardiovascular remodelling in subjects with essential hypertension: the results of a randomized, double-blind, active-controlled study.
Topics: Aminobutyrates; Angiotensin Receptor Antagonists; Antihypertensive Agents; Aorta; Aorta, Thoracic; Biphenyl Compounds; Blood Pressure; Double-Blind Method; Drug Combinations; Essential Hypertension; Female; Heart Failure; Humans; Hypertrophy, Left Ventricular; Imidazoles; Magnetic Resonance Angiography; Male; Medication Adherence; Middle Aged; Neprilysin; Tetrazoles; Valsartan; Vascular Stiffness; Ventricular Remodeling | 2017 |
Supplemental benefit of an angiotensin receptor blocker in hypertensive patients with stable heart failure using olmesartan (SUPPORT) trial--rationale and design.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Drug Therapy, Combination; Heart Failure; Humans; Hypertension; Imidazoles; Prospective Studies; Tetrazoles; Treatment Outcome | 2013 |
Clinical impacts of additive use of olmesartan in hypertensive patients with chronic heart failure: the supplemental benefit of an angiotensin receptor blocker in hypertensive patients with stable heart failure using olmesartan (SUPPORT) trial.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Chronic Disease; Drug Therapy, Combination; Female; Heart Failure; Humans; Hypertension; Imidazoles; Kaplan-Meier Estimate; Male; Medication Adherence; Prospective Studies; Tetrazoles; Treatment Outcome | 2015 |
Influence of Left Ventricular Ejection Fraction on the Effects of Supplemental Use of Angiotensin Receptor Blocker Olmesartan in Hypertensive Patients With Heart Failure.
Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Disease-Free Survival; Female; Follow-Up Studies; Heart Failure; Humans; Hypertension; Imidazoles; Kidney; Male; Middle Aged; Prospective Studies; Stroke Volume; Survival Rate; Tetrazoles | 2016 |
Comparison of the effects of telmisartan and olmesartan on home blood pressure, glucose, and lipid profiles in patients with hypertension, chronic heart failure, and metabolic syndrome.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Glucose; Blood Pressure; Chronic Disease; Female; Glycated Hemoglobin; Heart Failure; Heart Rate; Humans; Hypertension; Imidazoles; Lipid Metabolism; Lipids; Longitudinal Studies; Male; Metabolic Syndrome; Middle Aged; Natriuretic Peptide, Brain; Telmisartan; Tetrazoles | 2008 |
16 other study(ies) available for olmesartan and Heart Failure
| Article | Year |
|---|---|
High-dose nitrate therapy recovers the expression of subtypes α
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Disease Models, Animal; Drug Therapy, Combination; Heart Failure; Imidazoles; Isosorbide Dinitrate; Kidney Cortex; Male; Myocardial Infarction; Rats, Wistar; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, beta; Receptors, Angiotensin; Renin-Angiotensin System; Tetrazoles; Time Factors | 2020 |
Effect of Gonadectomy and Angiotensin II Receptor Blockade in a Mouse Model of Isoproterenol-induced Cardiac Diastolic Dysfunction.
Topics: Angiotensin Receptor Antagonists; Animals; Cardiomegaly; Castration; Diastole; Disease Models, Animal; Echocardiography; Female; Heart Failure; Heart Ventricles; Humans; Imidazoles; Isoproterenol; Male; Mice, Inbred Strains; Stroke Volume; Tetrazoles | 2021 |
Angiotensin receptor blocker use and gastro-oesophageal cancer survival: a population-based cohort study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Benzimidazoles; Biphenyl Compounds; Child; Child, Preschool; Cohort Studies; Diabetic Neuropathies; Esophageal Neoplasms; Female; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Imidazoles; Infant; Infant, Newborn; Losartan; Male; Middle Aged; Registries; Stomach Neoplasms; Survival Analysis; Tetrazoles; Young Adult | 2018 |
Cardiac overexpression of constitutively active Galpha q causes angiotensin II type1 receptor activation, leading to progressive heart failure and ventricular arrhythmias in transgenic mice.
Topics: Adaptor Proteins, Signal Transducing; Animals; Atrial Natriuretic Factor; Collagen Type I; Disease Models, Animal; Gene Expression Regulation; GTP-Binding Protein alpha Subunits, Gq-G11; Heart Failure; Imidazoles; Mice; Mice, Transgenic; Myosin Heavy Chains; Tetrazoles; Ventricular Premature Complexes | 2014 |
Effects of olmesartan therapy on the expression of lung adrenoceptors in rats with chronic heart failure.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cell Proliferation; Chronic Disease; Heart Failure; Imidazoles; Lung; Male; Rats; Rats, Wistar; Receptors, Adrenergic; Renin; RNA, Messenger; Tetrazoles | 2015 |
Superoxide-dependent cathepsin activation is associated with hypertensive myocardial remodeling and represents a target for angiotensin II type 1 receptor blocker treatment.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Cathepsins; Cells, Cultured; Fibrosis; Heart Failure; Humans; Hypertension; Imidazoles; Leucine; Myocardium; Myocytes, Cardiac; NADPH Oxidases; Rats; Rats, Inbred Dahl; Receptor, Angiotensin, Type 1; Sodium Chloride; Superoxides; Tetrazoles; Ventricular Remodeling | 2008 |
Mast cells and epsilonPKC: a role in cardiac remodeling in hypertension-induced heart failure.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Cell Degranulation; Heart Failure; Hypertension; Hypertrophy, Left Ventricular; Imidazoles; Male; Mast Cells; Protein Kinase C-delta; Protein Kinase C-epsilon; Protein Kinase Inhibitors; Rats; Rats, Inbred Dahl; Signal Transduction; Tetrazoles; Time Factors | 2008 |
Mechanism of diastolic stiffening of the failing myocardium and its prevention by angiotensin receptor and calcium channel blockers.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Azetidinecarboxylic Acid; Calcium Channel Blockers; Diastole; Dihydropyridines; Heart Failure; Imidazoles; Male; Myocardium; Rats; Rats, Inbred Dahl; Receptor, Angiotensin, Type 1; Tetrazoles | 2009 |
Effects of olmesartan on Apelin/APJ and Akt/endothelial nitric oxide synthase pathway in Dahl rats with end-stage heart failure.
Topics: Adipokines; Angiotensin II Type 1 Receptor Blockers; Animals; Apelin; Apelin Receptors; Carrier Proteins; Disease Models, Animal; Down-Regulation; Heart Failure; Imidazoles; Intercellular Signaling Peptides and Proteins; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Rats, Inbred Dahl; Receptors, G-Protein-Coupled; Signal Transduction; Tetrazoles | 2010 |
Olmesartan associated with acute renal failure in a patient with bilateral renal artery stenosis.
Topics: Acute Kidney Injury; Aged; Angiotensin II Type 1 Receptor Blockers; Heart Failure; Humans; Hypertension; Imidazoles; Male; Renal Artery Obstruction; Tetrazoles | 2010 |
Olmesartan, an AT1 antagonist, attenuates oxidative stress, endoplasmic reticulum stress and cardiac inflammatory mediators in rats with heart failure induced by experimental autoimmune myocarditis.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Autoimmune Diseases; Blotting, Western; Chemokine CCL2; Endoplasmic Reticulum; Heart; Heart Failure; Imidazoles; Immunohistochemistry; Interferon-gamma; Interleukin-1beta; Male; Myocarditis; Myocardium; Oxidative Stress; Rats; Receptor, Angiotensin, Type 1; Reverse Transcriptase Polymerase Chain Reaction; Tetrazoles; Tumor Necrosis Factor-alpha | 2011 |
Olmesartan attenuates the development of heart failure after experimental autoimmune myocarditis in rats through the modulation of ANG 1-7 mas receptor.
Topics: Angiotensin I; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Apoptosis; Autoimmune Diseases; Cardiotonic Agents; Endoplasmic Reticulum Stress; Heart Failure; Imidazoles; Inflammation; JNK Mitogen-Activated Protein Kinases; Membrane Glycoproteins; Myocarditis; NADPH Oxidase 4; NADPH Oxidases; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Peptide Fragments; Peptidyl-Dipeptidase A; Phosphatidylinositol 3-Kinases; Phosphoproteins; Proto-Oncogene Proteins c-akt; Rats; Rats, Inbred Lew; Receptor, Angiotensin, Type 1; Receptors, Interleukin-1; RNA, Messenger; Tetrazoles | 2012 |
Additive amelioration of oxidative stress and cardiac function by combined mineralocorticoid and angiotensin receptor blockers in postinfarct failing hearts.
Topics: Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Animals, Newborn; Cells, Cultured; Disease Models, Animal; Drug Therapy, Combination; Heart Failure; Hemodynamics; Imidazoles; Lipid Peroxidation; Male; Mineralocorticoid Receptor Antagonists; Myocardial Infarction; Myocardium; NADPH Oxidases; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptors, Mineralocorticoid; Spironolactone; Tetrazoles; Ventricular Function, Left | 2012 |
Prolonged endoplasmic reticulum stress in hypertrophic and failing heart after aortic constriction: possible contribution of endoplasmic reticulum stress to cardiac myocyte apoptosis.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aortic Valve Stenosis; Apoptosis; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Disease Progression; Endoplasmic Reticulum; Gene Expression Regulation; Heart Failure; Humans; Imidazoles; Ligation; Male; Mice; Mice, Inbred C57BL; Molecular Chaperones; Myocytes, Cardiac; Natriuretic Peptide, Brain; Olmesartan Medoxomil; Rats; Rats, Inbred WKY; RNA, Messenger; Signal Transduction; Stress, Physiological; Tetrazoles; Thapsigargin; Tunicamycin | 2004 |
Therapeutic effects of angiotensin II type 1 receptor blocker at an advanced stage of hypertensive diastolic heart failure.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Chemokine CCL2; Heart Failure; Hypertension; Hypertrophy, Left Ventricular; Imidazoles; Inflammation; Male; NADPH Oxidases; Oxidative Stress; Random Allocation; Rats; Rats, Inbred Dahl; Reactive Oxygen Species; Tetrazoles; Transforming Growth Factor beta1; Ventricular Remodeling | 2007 |
Pharmacological inhibition of epsilon-protein kinase C attenuates cardiac fibrosis and dysfunction in hypertension-induced heart failure.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Cardiomegaly; Drug Therapy, Combination; Enzyme Inhibitors; Heart Failure; Hypertension; Imidazoles; Male; Protein Kinase C-epsilon; Rats; Rats, Inbred Dahl; Sodium Chloride, Dietary; Tetrazoles | 2008 |